InVivo Therapeutics (NASDAQ:NVIV) Earns Sell Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a report published on Sunday morning. The firm issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Trading Up 3.6 % Shares of InVivo Therapeutics stock opened at $0.78 on Friday. The business has a 50-day moving average price of […]
More Stories
StockNews.com Downgrades Grupo Financiero Galicia (NASDAQ:GGAL) to Hold
StockNews.com lowered shares of Grupo Financiero Galicia (NASDAQ:GGAL – Free Report) from a buy rating to a hold rating in...
Gilead Sciences (NASDAQ:GILD) Earns Buy Rating from Analysts at Citigroup
Citigroup started coverage on shares of Gilead Sciences (NASDAQ:GILD – Free Report) in a research note published on Thursday morning,...
CoStar Group, Inc. (NASDAQ:CSGP) Holdings Decreased by Kentucky Retirement Systems Insurance Trust Fund
Kentucky Retirement Systems Insurance Trust Fund cut its position in shares of CoStar Group, Inc. (NASDAQ:CSGP – Free Report) by...
Natixis Advisors LLC Buys 8,107 Shares of The Allstate Co. (NYSE:ALL)
Natixis Advisors LLC increased its stake in The Allstate Co. (NYSE:ALL – Free Report) by 3.4% in the 3rd quarter,...
Kentucky Retirement Systems Insurance Trust Fund Has $1.14 Million Holdings in Sysco Co. (NYSE:SYY)
Kentucky Retirement Systems Insurance Trust Fund trimmed its stake in Sysco Co. (NYSE:SYY – Free Report) by 9.4% during the...
Kentucky Retirement Systems Insurance Trust Fund Sells 363 Shares of Dover Co. (NYSE:DOV)
Kentucky Retirement Systems Insurance Trust Fund lowered its position in shares of Dover Co. (NYSE:DOV – Free Report) by 8.2%...